Analysis from the Oncomine indicated that ACSL4 was down-regulated in bladder, brain, breast, leukemia, and lung cancer, but up-regulated in colorectal cancer, head and neck, kidney, myeloma, and liver cancer (Fig 5A and S5 Table). This evidence concerns the gene ACSL4 and lung cancer.